Liberia has experimental Ebola drug

Liberia is facing an excruciating choice – deciding which handful of Ebola patients will receive an experimental drug that could prove either life-saving or life-threatening.

Liberia has experimental Ebola drug

Liberia is facing an excruciating choice – deciding which handful of Ebola patients will receive an experimental drug that could prove either life-saving or life-threatening.

ZMapp, the untested Ebola drug, arrived in the West African country late yesterday.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €130 €65

Best value

Monthly €12€6 / month

More in this section

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited